Cordlife Group Limited (CLIFF)
USD 0.3
(0.0%)
USD 0.3
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.69 Million SGD | 66.21% |
| 2022 | 1.01 Million USD | 20.76% |
| 2021 | 843 Thousand SGD | -69.71% |
| 2020 | 2.78 Million SGD | -6.36% |
| 2019 | 2.97 Million SGD | -31.05% |
| 2018 | 4.31 Million SGD | -3.49% |
| 2017 | 4.46 Million SGD | -32.47% |
| 2016 | 6.61 Million SGD | -91.32% |
| 2015 | 76.14 Million SGD | -17.86% |
| 2014 | 92.69 Million SGD | 1003.29% |
| 2013 | 8.4 Million SGD | 41.78% |
| 2012 | 5.92 Million SGD | 141.58% |
| 2011 | 2.45 Million SGD | 40783.33% |
| 2010 | 6000.00 SGD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 2.63 Million SGD | 159.23% |
| 2023 Q2 | 2.63 Million USD | 0.0% |
| 2023 Q4 | 1.69 Million USD | 0.0% |
| 2023 FY | 1.69 Million SGD | 66.21% |
| 2023 Q3 | 1.69 Million SGD | -35.88% |
| 2022 Q1 | 813 Thousand SGD | -3.56% |
| 2022 FY | 1.01 Million USD | 20.76% |
| 2022 Q4 | 1.01 Million USD | 0.0% |
| 2022 Q3 | 1.01 Million SGD | 25.22% |
| 2022 Q2 | 813 Thousand SGD | 0.0% |
| 2021 Q1 | 1.42 Million SGD | -75.29% |
| 2021 Q3 | 843 Thousand SGD | -40.8% |
| 2021 Q4 | 843 Thousand SGD | 0.0% |
| 2021 FY | 843 Thousand SGD | -69.71% |
| 2021 Q2 | 1.42 Million SGD | 0.0% |
| 2020 Q2 | 4.91 Million SGD | 0.0% |
| 2020 Q3 | 5.76 Million SGD | 17.28% |
| 2020 Q4 | 5.76 Million SGD | 0.0% |
| 2020 FY | 2.78 Million SGD | -6.36% |
| 2020 Q1 | 4.91 Million SGD | -8.15% |
| 2019 Q4 | 5.35 Million SGD | 31.26% |
| 2019 Q1 | 4.23 Million SGD | -1.74% |
| 2019 FY | 2.97 Million SGD | -31.05% |
| 2019 Q2 | 4.15 Million SGD | -1.91% |
| 2019 Q3 | 4.07 Million SGD | -1.88% |
| 2018 Q2 | 4.46 Million SGD | -1.8% |
| 2018 FY | 4.31 Million SGD | -3.49% |
| 2018 Q4 | 4.31 Million SGD | -1.78% |
| 2018 Q3 | 4.38 Million SGD | -1.75% |
| 2018 Q1 | 4.54 Million SGD | -1.56% |
| 2017 Q4 | 4.62 Million SGD | -13.93% |
| 2017 FY | 4.46 Million SGD | -32.47% |
| 2017 Q3 | 5.36 Million SGD | -18.83% |
| 2017 Q2 | 6.61 Million SGD | -0.94% |
| 2017 Q1 | 6.67 Million SGD | -1.08% |
| 2016 Q4 | 6.74 Million SGD | -91.01% |
| 2016 FY | 6.61 Million SGD | -91.32% |
| 2016 Q3 | 75.08 Million SGD | -1.39% |
| 2016 Q2 | 76.14 Million SGD | 0.1% |
| 2016 Q1 | 76.06 Million SGD | -5.7% |
| 2015 FY | 76.14 Million SGD | -17.86% |
| 2015 Q4 | 80.66 Million SGD | -36.67% |
| 2015 Q3 | 127.36 Million SGD | 2.04% |
| 2015 Q2 | 124.81 Million SGD | 0.44% |
| 2015 Q1 | 124.26 Million SGD | -0.07% |
| 2014 Q1 | 11.96 Million SGD | -0.52% |
| 2014 Q4 | 124.34 Million SGD | 1396.02% |
| 2014 Q3 | 8.31 Million SGD | -1.07% |
| 2014 Q2 | 8.4 Million SGD | -29.77% |
| 2014 FY | 92.69 Million SGD | 1003.29% |
| 2013 Q3 | 5.86 Million SGD | -1.0% |
| 2013 Q4 | 12.02 Million SGD | 104.98% |
| 2013 FY | 8.4 Million SGD | 41.78% |
| 2013 Q1 | 5.21 Million SGD | -1.08% |
| 2013 Q2 | 5.92 Million SGD | 13.68% |
| 2012 Q1 | 1.89 Million SGD | 0.0% |
| 2012 FY | 5.92 Million SGD | 141.58% |
| 2012 Q2 | 2.45 Million SGD | 29.58% |
| 2012 Q4 | 5.27 Million SGD | -1.05% |
| 2012 Q3 | 5.32 Million SGD | 117.12% |
| 2011 Q2 | 6000.00 SGD | 0.0% |
| 2011 FY | 2.45 Million SGD | 40783.33% |
| 2010 FY | 6000.00 SGD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -28100.0% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -30.403% |
| Biocept, Inc. | 10.37 Million USD | 83.692% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 96.702% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 97.236% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -209.706% |
| iMD Companies, Inc. | 1.1 Million USD | -53.307% |
| IDenta Corp. | 428.17 Thousand USD | -295.165% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 60.123% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -508.633% |
| NovelStem International Corp. | 3.32 Million USD | 49.107% |
| Optigenex Inc. | 4.42 Million USD | 61.781% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -3.74% |
| Response Genetics, Inc | 4.91 Million USD | 65.596% |
| Rennova Health, Inc. | 359.19 Thousand USD | -371.056% |
| RushNet, Inc. | 4.25 Million USD | 60.211% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -579.382% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -111.913% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -193.555% |
| Todos Medical Ltd. | 33 Million USD | 94.873% |